GSK | GSK plc Stock Overview

(Stock Exchange: NYSE)

Day's Range	39.23 - 40.38
52 Week Range	31.72 - 45.93
Beta	0.50
Implied Volatility	24.43%
IV Rank	45.68%
Day's Volume	8,015,980
Average Volume	5,660,921
Shares Outstanding	2,025,974,697
Market Cap	80,735,091,675
Sector	Healthcare
Industry	Drug Manufacturers - General
IPO Date	1980-03-28

Valuation
Profitability
Growth
Health
P/E Ratio	24.15
Forward P/E Ratio	12.26
EPS	1.65
1YR Price Target	51.00
Dividend Yield	4.38%
Dividend Per Share	1.74
Dividend ExDate	2022-08-18
Dividend PayDate	2022-10-06
Employees	70,212
Country	UK
Website	GSK

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines.

GSK's peers: AMRN, AZN, BIIB, GRFS, NVS, RHHBY, BMY, AMGN, MRK, ABBV, GILD, JNJ, SNY, SCLX

*Chart delayed

Analyzing fundamentals for GSK we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is very poor, Growth is very bad and Health is weak. For more detailed analysis please see GSK Fundamentals page.

Watching at GSK technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on GSK Technicals page.